nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Mometasone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Gallamine Triethiodide—Confusional state—Captopril—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Lisinopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Leflunomide—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Gallamine Triethiodide—Anaemia—Azathioprine—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Gallamine Triethiodide—Fatigue—Mometasone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Captopril—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Captopril—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Gallamine Triethiodide—Pain—Mometasone—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Gallamine Triethiodide—Malaise—Azathioprine—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Azathioprine—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Gallamine Triethiodide—Asthenia—Pentoxifylline—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Gallamine Triethiodide—Pruritus—Pentoxifylline—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Gallamine Triethiodide—Anaemia—Leflunomide—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Gallamine Triethiodide—Angioedema—Leflunomide—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Malaise—Leflunomide—systemic scleroderma	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Azathioprine—systemic scleroderma	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Leflunomide—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mometasone—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mometasone—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Captopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Methotrexate—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Gallamine Triethiodide—Anaemia—Mycophenolic acid—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Gallamine Triethiodide—Cough—Leflunomide—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Gallamine Triethiodide—Malaise—Mycophenolic acid—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Gallamine Triethiodide—Fatigue—Captopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Chest pain—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Lisinopril—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Azathioprine—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Gallamine Triethiodide—Cough—Mycophenolic acid—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Gallamine Triethiodide—Vomiting—Pentoxifylline—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Gallamine Triethiodide—Rash—Pentoxifylline—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Pentoxifylline—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Gallamine Triethiodide—Headache—Pentoxifylline—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Captopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Gallamine Triethiodide—Chest pain—Mycophenolic acid—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mometasone—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Gallamine Triethiodide—Pruritus—Mometasone—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Leflunomide—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Gallamine Triethiodide—Anaemia—Lisinopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Leflunomide—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Gallamine Triethiodide—Angioedema—Lisinopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Confusional state—Mycophenolic acid—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Captopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Captopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Nausea—Pentoxifylline—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Malaise—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mometasone—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Gallamine Triethiodide—Cough—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Leflunomide—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Gallamine Triethiodide—Chest pain—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mometasone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gallamine Triethiodide—Rash—Mometasone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gallamine Triethiodide—Asthenia—Captopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mometasone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Confusional state—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Headache—Mometasone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Fatigue—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Pruritus—Captopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Gallamine Triethiodide—Pain—Leflunomide—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Gallamine Triethiodide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Gallamine Triethiodide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Lisinopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Azathioprine—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Azathioprine—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Gallamine Triethiodide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Captopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Fatigue—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Nausea—Mometasone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Pain—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Gallamine Triethiodide—Cough—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Urticaria—Leflunomide—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Lisinopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Gallamine Triethiodide—Vomiting—Captopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Gallamine Triethiodide—Rash—Captopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Captopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Gallamine Triethiodide—Headache—Captopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Fatigue—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Pain—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Azathioprine—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Gallamine Triethiodide—Nausea—Captopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Gallamine Triethiodide—Asthenia—Leflunomide—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Gallamine Triethiodide—Pruritus—Leflunomide—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Leflunomide—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Urticaria—Lisinopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Gallamine Triethiodide—Pruritus—Mycophenolic acid—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Gallamine Triethiodide—Vomiting—Azathioprine—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Gallamine Triethiodide—Rash—Azathioprine—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Azathioprine—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Gallamine Triethiodide—Headache—Azathioprine—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Pain—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Gallamine Triethiodide—Vomiting—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Rash—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Nausea—Azathioprine—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Headache—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Gallamine Triethiodide—Asthenia—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Gallamine Triethiodide—Pruritus—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Rash—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Headache—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Nausea—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Gallamine Triethiodide—Anaemia—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Angioedema—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Gallamine Triethiodide—Nausea—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gallamine Triethiodide—Vomiting—Lisinopril—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Gallamine Triethiodide—Rash—Lisinopril—systemic scleroderma	0.000982	0.000982	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Lisinopril—systemic scleroderma	0.000981	0.000981	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Gallamine Triethiodide—Headache—Lisinopril—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Gallamine Triethiodide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Prednisone—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000933	0.000933	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Gallamine Triethiodide—Nausea—Lisinopril—systemic scleroderma	0.000925	0.000925	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Prednisone—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Prednisone—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Gallamine Triethiodide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Gallamine Triethiodide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Prednisone—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Gallamine Triethiodide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Gallamine Triethiodide—Fatigue—Prednisone—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Prednisone—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisone—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Prednisone—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Prednisone—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Gallamine Triethiodide—Asthenia—Prednisone—systemic scleroderma	0.000664	0.000664	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Gallamine Triethiodide—Pruritus—Prednisone—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Prednisone—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Gallamine Triethiodide—Vomiting—Prednisone—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisone—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisone—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisone—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Gallamine Triethiodide—Asthenia—Methotrexate—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisone—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Gallamine Triethiodide—Vomiting—Methotrexate—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Gallamine Triethiodide—Rash—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Gallamine Triethiodide—Headache—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Gallamine Triethiodide—Nausea—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
